Business
Eurofins Viracor BioPharma Announces Relocation to New State-of-the-Art Facility
LENEXA, Kan., August 29, 2025--Eurofins Viracor BioPharma Services, a recognized leader in analytical testing and clinical trial services, announces the infrastructure enhancement of its headquarters and laboratory operations to a new, custom-built 96,000 sq. ft. facility in Lenexa, Kansas, scheduled for completion in September 2025. This strategic move, although only a few miles from its previous location, marks a significant milestone in the company’s continued growth and commitment to deliver
About this update from Eurofins Scientific Se
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1518,"height":299,"url":"https://media.zenfs.com/en/business-wire.com/b69698669569b8c3f7011c2eccca8d21"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/R6CDrVN17.3sPExaRZX_Bw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE4OTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/b69698669569b8c3f7011c2eccca8d21","width":960,"height":189},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/xOV1dnrfUjwwaDcqkk8C_w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD00NzI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/b69698669569b8c3f7011c2eccca8d21","width":1200,"height":236}},"lazy":false},{"type":"text","content":"LENEXA, Kan., August 29, 2025--(BUSINESS WIRE)--Eurofins Viracor BioPharma Services, a recognized leader in analytical testing and clinical trial services, announces the infrastructure enhancement of its headquarters and laboratory operations to a new, custom-built 96,000 sq. ft. facility in Lenexa, Kansas, scheduled for completion in September 2025. This strategic move, although only a few miles from its previous location, marks a significant milestone in the company’s continued growth and commitment to delivering cutting-edge solutions to the biopharmaceutical industry.","length":578,"tagName":"p"},{"type":"text","content":"Eurofins Viracor BioPharma Services was formally spun out of Eurofins Viracor in 2020 to focus exclusively on supporting biopharmaceutical sponsors with specialized analytical and clinical trial services. Previously, both companies operated from the same facility, but with Eurofins Viracor BioPharma’s relocation to a new, dedicated space, each organization can better concentrate on its core market—Eurofins Viracor on clinical diagnostics and Eurofins Viracor BioPharma on biopharma services. This separation allows both to take full advantage of the strategic benefits offered by the Kansas City region, including access to top-tier scientific talent, centralized logistics, and a thriving life sciences ecosystem that fosters innovation and growth.","length":753,"tagName":"p"},{"type":"text","content":"The new facility supports the increasing demand for advanced testing services, particularly in the areas of sequencing and precision medicine, cell-based assays, high-complexity flow ...